| |

Epigenetic targeted drugs

Byscientist

Many pathways to hit in epigenomics to target cancer.

The picture is from this article:

Dai, W., Qiao, X., Fang, Y. et al. Epigenetics-targeted drugs: current paradigms and future challenges. Sig Transduct Target Ther 9, 332 (2024).

https://doi.org/10.1038/s41392-024-02039-0

Similar Posts

  • Synthetic biology dyes

    Byscientist

    A synthetic biology company called Huue is going forward to create dye’s from bacteria. The cool part is that they are taking machinery that is in plants and introducing them into bacteria.An advantage is that you could manipulate and then come up with new dyes. The dye Huue has started with is called Indigo and…

  • |

    PROTAC databases

    Byscientist

    PROTAC (Proteolysis targeting chimera) is fantastic technology that can degrade specific proteins. It uses a small molecule with a capability to bind the protein to be degraded and an active site that binds to E3 ubiquitin ligase. Using the PROTAC pulls the protein into ubiquitin based degradation pathways by ubiquitination of the protein and subsequent…

  • Grunost

    Byscientist

    Grunost is a type of cheese that is sweet and often typical of Norways’ cheese culture. It is incidentally not a cheese at all since it is made from the process of making cheese that leaves whey as a by product. This whey is boiled with milk or cream to make a brown caramelized cheese….

  • |

    ALS and TDP43

    Byscientist

    Almost 90% of ALS is thought to be sporadic. The reasons are not well understood and thought to be oxidative stress, damaged endoplasmic reticulum, mitochondria, cytoskeleton or misregulation of RNA pathways. One protein implicated is TDP43 which sits as a junction of ALS pathogenic path by binding to RNA modulation synthesis, splicing, stability and transport….